Best Per Spectives Podcasts (2025)

1
S2 Ep34: PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) 26:04

Play Pause

22d ago26:04

26:04

Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS Discus…

1
S2 Ep33: PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS) 24:46

22d ago24:46

24:46

Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Discuss the mechanisms of action, eff…

1
S2 Ep32: Breaking Barriers in HER2-Mutant NSCLC: Exploring the Promise of Next-Generation TKIs 26:11

25d ago26:11

26:11

Episode Description In this episode of the PER® podcast, we explore the evolving landscape of HER2-mutant non–small cell lung cancer (NSCLC)—a rare and historically difficult-to-treat subset of lung cancer. Join Millie Das, MD, from Stanford/VA Palo Alto; and Eric Kumar Singhi, MD, from The University of Texas MD Anderson Cancer Center; as they del…

1
S2 Ep31: Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies 1:04:32

1M ago1:04:32

1:04:32

Episode Description In this podcast, experts Andy Guinigundo, MSN, RN, CNP, ANP-BC, FAPO, and Fred Hirsch, MD, PhD, review the evolving treatment landscape for limited-stage small-cell lung cancer (LS-SCLC) and extensive-stage (ES) SCLC, including a discussion of the latest strategies for managing common and severe treatment-related adverse events.…

1
S2 Ep30: Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer 1:26:00

2M ago1:26:00

1:26:00

Episode Description This PER® Show Me Your Care Plan!™ featured podcast brings together two medical oncologists and an oncology nurse to discuss the latest advances in the management of platinum-resistant ovarian cancer (PROC). The expert panel reviews current and emerging therapies, with a special focus on the management of adverse events associat…

1
S2 Ep29: Oncology PER® Spectives™: Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma 30:09

5M ago30:09

30:09

By PER® Spectives

1
S2 Ep28: Oncology PER® Spectives™: Oncology Consultations®: Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases 29:33

5M ago29:33

29:33

By PER® Spectives

1
S2 Ep27: Oncology PER® Spectives™: Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision Making and Future Therapies 52:01

6M ago52:01

52:01

By PER® Spectives

1
S2 Ep26: Cases & Conversations: Integrating Novel Approaches to Treatment in First-Line ALK+ mNSCLC Enhancing Patient Outcomes with Real World Multidisciplinary Strategies 41:10

6M ago41:10

41:10

By PER® Spectives

1
S2 Ep25: Oncology PER® Spectives™: Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations 57:25

6M ago57:25

57:25

By PER® Spectives

1
S2 Ep24: Oncology PER® Spectives™: Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma 44:42

6M ago44:42

44:42

By PER® Spectives

1
S2 Ep23: Oncology PER® Spectives™: PSMA in Prostate Cancer: Precision Medicine in Imaging & Therapy 50:18

6M ago50:18

50:18

By PER® Spectives

1
S2 Ep22: PsychPearls Podcast: Optimizing the Management of Tardive Dyskinesia – Addressing the Complexity of Care with Targeted Treatment 11:09

7M ago11:09

11:09

Tardive dyskinesia (TD), a neurological disorder characterized by involuntary movement, is commonly associated with exposure to antipsychotic medication. The disorder can have significant impacts on patient quality of life due to functional challenges and social stigmatization. Comprehensive assessment of TD burden and severity is needed to guide t…

1
S2 Ep21: Burst CME™: Tackling Adverse Events with Targeted Therapies for Diffuse B-cell Lymphoma 33:30

7M ago33:30

33:30

By PER® Spectives

1
S2 Ep20: Burst CME™: Tackling Adverse Events with Targeted Therapies for Diffuse B-cell Lymphoma 29:35

7M ago29:35

29:35

By PER® Spectives

1
S2 Ep19: Burst CME™: Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches 29:49

7M ago29:49

29:49

By PER® Spectives

1
S2 Ep18: Biomarkers in Diffuse Large B-cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes 29:35

8M ago29:35

29:35

By PER® Spectives

1
S2 Ep17: Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis 43:34

8M ago43:34

43:34

By PER® Spectives

1
S2 Ep16: Patient, Provider, & Caregiver Connection: Individualizing Care in Hemophilia A to Optimize Joint Health and Prevent Synovitis 40:44

10M ago40:44

40:44

By PER® Spectives

1
S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies 18:11

1+ y ago18:11

18:11

This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use o…

1
S2 Ep14: Postpartum Depression: A Multidisciplinary Approach to Management 11:46

1+ y ago11:46

11:46

This podcast explores the diagnosis and management of postpartum depression with a focus on the importance of screening all postpartum women and treatment options. Two faculty, Sarah Nagle-Yang, MD, and Lindsey Lebin, MD, discuss the importance of an early diagnosis with each other, and a patient shares her journey living with postpartum depression…

1
S2 Ep13: Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment 35:14

1+ y ago35:14

35:14

This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy. Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia. Faculty Hanny Al-Samkari, MD Classical Hematologist and C…

1
S2 Ep12: Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management 21:10

1+ y ago21:10

21:10

This podcast features engaging commentary from experts in the clinical management of generalized myasthenia gravis— James Howard, Jr, MD and Nicholas Sylvestri, MD. These experts discuss the burden of disease associated with the disorder, its pathogenesis in terms of the complement system, and the clinical considerations for incorporating appropria…

1
S2 Ep11: Advances in Topical Treatment for Presbyopia 24:11

2y ago24:11

24:11

This PER®Spectives™ podcast examines treatment of presbyopia with a focus on new and emerging topical therapies. In this podcast, experts Mile Brujic, OD, FAAO, and Jay Pepose, MD, PhD, describe these agents and how to select patients with presbyopia who will benefit from topical treatment. Faculty: Mile Brujic, OD, FAAO Premier Vision Group Bowlin…

1
S2 Ep10: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care 27:52

2y ago27:52

27:52

Optometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as t…

1
S2 Ep9: Clinical Pearls in Co-Managing Glaucoma 12:13

2y ago12:13

12:13

This PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS). Faculty Danica J. Marrelli, OD, FAAO, AAO College of Optome…

1
S2 Ep8: Advances in Treatment for Geographic Atrophy 28:33

2y ago28:33

28:33

This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did. Faculty David S. Boyer, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Tina Mac Donal…

1
S2 Ep7: Looking at the Lid – Reducing Patient Burden in Blepharoptosis & Demodex Blepharitis 14:51

2y ago14:51

14:51

Welcome to a podcast based on learning about the lid: optimizing recognition, diagnosis, and treatment of Demodex Blepharitis and Blepharoptosis. In this podcast, we will hear from Dr Mile Brujic and Dr Cecelia Koetting. Faculty Mile Brujic, OD, FAAO Partner Premier Vision Group Bowling Green, OH Cecelia Koetting, OD, FAAO, DipABO Optometrist Denve…

1
S2 Ep6: Thyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative Care 25:51

2y ago25:51

25:51

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients. Faculty Steven Leibowitz, MD Associate Clinical Professor, Oculoplastics and Orbit Jules Stein Eye Institu…

1
S2 Ep5: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis 30:33

2y ago30:33

30:33

In this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients. Faculty Gus Alva, MD, DFAPA Medi…

1
S2 Ep4: Catching and Addressing Early Neurotropic Keratitis: New Perspectives 14:17

2y ago14:17

14:17

Neurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes. This feat…

1
S2 Ep3: Facing the Changing Landscape for Neuromodulators and Dermal Fillers 24:39

2+ y ago24:39

24:39

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below. This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in…

1
S2 Ep2: Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis 58:39

2+ y ago58:39

58:39

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below. This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care,…

1
S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm 18:42

2+ y ago18:42

18:42

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking.…

1
S1 Ep9: Advances in Sickle Cell Disease Management 29:34

2+ y ago29:34

29:34

This podcast features engaging commentary from experts in the clinical management of patients with sickle cell disease: Nirmish Shad, MD from Duke University Medical Center, Matthew Heeney, MD Matthew Heeney, MD from Harvard Medical School, and Charles R. Jonassaint, PhD, MHS from University of Pittsburgh School of Medicine. These experts review cl…

1
S1 Ep8: Part 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhD 18:02

3y ago18:02

18:02

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 2 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with David Gandara MD 7:48

3y ago7:48

7:48

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 3 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Charu Aggarwal MD, MPH 6:13

3y ago6:13

6:13

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 4 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Julia Rotow MD 17:18

3y ago17:18

17:18

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep7: Part 5 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Balazs Halmos MD, MS 10:07

3y ago10:07

10:07

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep6: Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer 49:22

3y ago49:22

49:22

During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer. Featuring: Fátima Cardoso, MD Director, Breast Unit Champalimaud Clinical Center Li…

1
S1 Ep5: Managing Your Patients with CKD 45:26

3y ago45:26

45:26

Dr. Eden Miller and Kim Zuber, PA-C, discuss the importance of screening patients with chronic kidney disease (CKD) for comorbidities and treating them early. They also discuss the treatment options available among both current and emerging classes of therapies and across different clinical subspecialties. After you listen to this podcast, go to ht…

1
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 23:04

3+ y ago23:04

23:04

Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will…